| Stage | PAHC | % of rev | LLY | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $387M | 100.00% | $24.4B | 100.00% | LLY ×63.08 |
| Gross profit | $129M | 33.23% | $20.5B | 83.88% | LLY +50.6pp |
| Operating income | $50M | 12.83% | $8.6B | 35.28% | LLY +22.4pp |
| Pre-tax income | $39M | 10.03% | $8.4B | 34.46% | LLY +24.4pp |
| Net income | $30M | 7.63% | $6.5B | 26.44% | LLY +18.8pp |
| Stage | PAHC | LLY | Gap · A − B |
|---|---|---|---|
| Revenue | $387M100.00% | $24.4B100.00% | LLY ×63.08 |
| Gross profit | 33.23%$129M | 83.88%$20.5B | LLY +50.6pp |
| Operating income | 12.83%$50M | 35.28%$8.6B | LLY +22.4pp |
| Pre-tax income | 10.03%$39M | 34.46%$8.4B | LLY +24.4pp |
| Net income |
| 7.63%$30M |
| 26.44%$6.5B |
| LLY +18.8pp |
No shared counterparties.